These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30604139)

  • 1. Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE).
    Algharably EAH; Kreutz R; Gundert-Remy U
    Arch Toxicol; 2019 Mar; 93(3):615-621. PubMed ID: 30604139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation.
    Algharably EAE; Di Consiglio E; Testai E; Kreutz R; Gundert-Remy U
    Arch Toxicol; 2021 Apr; 95(4):1433-1442. PubMed ID: 33606068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-mechanistic physiologically-based pharmacokinetic modeling of clinical glibenclamide pharmacokinetics and drug-drug-interactions.
    Greupink R; Schreurs M; Benne MS; Huisman MT; Russel FG
    Eur J Pharm Sci; 2013 Aug; 49(5):819-28. PubMed ID: 23806476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept.
    Sugiyama Y; Aoki Y
    Drug Metab Dispos; 2023 Sep; 51(9):1067-1076. PubMed ID: 37407092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of protein binding for the in vitro-in vivo extrapolation (IVIVE)-example of ibuprofen, a highly protein-bound substance.
    Mielke H; Di Consiglio E; Kreutz R; Partosch F; Testai E; Gundert-Remy U
    Arch Toxicol; 2017 Apr; 91(4):1663-1670. PubMed ID: 27770144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating in vitro testing and physiologically-based pharmacokinetic (PBPK) modelling for chemical liver toxicity assessment-A case study of troglitazone.
    Yu L; Li H; Zhang C; Zhang Q; Guo J; Li J; Yuan H; Li L; Carmichael P; Peng S
    Environ Toxicol Pharmacol; 2020 Feb; 74():103296. PubMed ID: 31783317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Incorporating Plasma Lipoprotein Binding into a Physiologically-Based Pharmacokinetic Model: A Simulation Study with Amiodarone.
    Doki K; Hashimoto N; Yoshida K; Homma M
    Clin Pharmacol Ther; 2024 May; 115(5):1015-1024. PubMed ID: 38093601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics.
    Song L; Zhang Y; Jiang J; Ren S; Chen L; Liu D; Chen X; Hu P
    Clin Pharmacokinet; 2018 Oct; 57(10):1307-1323. PubMed ID: 29626326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Prediction of Metabolic Clearance Using Quantitative Extrapolation of Results Obtained From Human Hepatic Micropatterned Cocultures Model and by Considering the Impact of Albumin Binding.
    Da-Silva F; Boulenc X; Vermet H; Compigne P; Gerbal-Chaloin S; Daujat-Chavanieu M; Klieber S; Poulin P
    J Pharm Sci; 2018 Jul; 107(7):1957-1972. PubMed ID: 29524447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results.
    Yoon M; Campbell JL; Andersen ME; Clewell HJ
    Crit Rev Toxicol; 2012 Sep; 42(8):633-52. PubMed ID: 22667820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods.
    Martin SA; McLanahan ED; Bushnell PJ; Hunter ES; El-Masri H
    Toxicol Sci; 2015 Feb; 143(2):512-35. PubMed ID: 25410581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods.
    Poulin P; Kenny JR; Hop CE; Haddad S
    J Pharm Sci; 2012 Feb; 101(2):838-51. PubMed ID: 22009717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug.
    Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M
    Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolite identification studies on amiodarone in in vitro (rat liver microsomes, rat and human liver S9 fractions) and in vivo (rat feces, urine, plasma) matrices by using liquid chromatography with high-resolution mass spectrometry and multiple-stage mass spectrometry: characterization of the diquinone metabolite supposedly responsible for the drug's hepatotoxicity.
    Ramesh Varkhede N; Jhajra S; Suresh Ahire D; Singh S
    Rapid Commun Mass Spectrom; 2014 Feb; 28(4):311-31. PubMed ID: 24395499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.